Sphera Funds Management Ltd. Bridge Bio Pharma, Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

A detailed history of Sphera Funds Management Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 842,644 shares of BBIO stock, worth $24 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares

842,644

Previous 910,070 7.41%

Holding current value

$24 Million

Previous $23.1 Million 6.94%

% of portfolio

3.93%

Previous 3.37%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $1.61 Million - $2.11 Million	-67,426 Reduced 7.41%	842,644 $21.5 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $7.45 Million - $10.1 Million	324,114 Added 55.31%	910,070 $23.1 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $8.31 Million - $12.3 Million	303,810 Added 107.68%	585,956 $18.1 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $1.52 Million - $2.78 Million	-63,391 Reduced 18.35%	282,146 $11.4 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $403,704 - $836,809	23,902 Added 7.43%	345,537 $9.11 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $3.19 Million - $4.33 Million	-240,348 Reduced 42.77%	321,635 $5.53 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $4.03 Million - $10.4 Million	561,983 New	561,983 $9.32 Million
Q2 2021 Aug 17, 2021	SELL	$46.47 - $63.93 $1.11 Million - $1.53 Million	-23,890 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $7.43 Million - $9.7 Million	-134,010 Reduced 84.87%	23,890 $1.47 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $6.06 Million - $11.2 Million	157,900 New	157,900 $11.2 Million

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Bridge Bio Pharma, Inc. Transaction History